| Meclozine Hydrochloride Imp. C (EP): (4-Chlorophenyl)phenyl- methanone (4-Chlorobenzophenone) | 134-85-0 | C13H9ClO |
| Meclozine Hydrochloride Imp. E (EP): 1-(Diphenylmethyl)-4-[(3-methyl- phenyl)methyl]piperazine | 16896-82-5 | C25H28N2 |
| Meclozine Hydrochloride Imp. H (EP): 1-[(RS)-(4-Chlorophenyl)phenyl- methyl]piperazine ((RS)-1-[(4-Chlorophenyl)- phenylmethyl]piperazine) | 303-26-4 | C17H19ClN2 |
| Meclozine impurity B | 119-56-2 | C13H11ClO |
| Meclozine impurity H | 303-26-4 | C17H19ClN2 |
| Meclozine N-Oxide | 114624-69-0 | C25H27ClN2O |
| Mecobalamin | 13422-55-4 | C63H91CoN13O14P |
| Medetomidine Impurity 3 | 40243-75-2 | C10H12 |
| Medetomidine Impurity 4 | 2514763-84-7 | C11H16O |
| Medetomidine Impurity 6 | 60907-90-6 | C10H14O |
| Medetomidine Impurity 9 | 104245-83-2 | C10H13Cl |
| Medetomidine Impurity 10 | 1021949-47-2 | C13H14N2 |
| Medetomidine Impurity 14 | 176721-04-3 | C17H22N2O6 |
| Medronic Acid Imp. B (EP): Tetrakis(1-methylethyl) Methylenediphosphonate | 1660-95-3 | C13H30O6P2 |
| Medronic acid impurity A | 116-17-6 | C9H21O3P |
| Medronic acid impurity B | 1660-95-3 | C13H30O6P2 |
| Medroxyprogesterone Acetate EP Impurity A | 984-47-4 | C24H34O5 |
| Medroxyprogesterone Acetate EP Impurity B | 520-85-4 | C22H32O3 |
| Medroxyprogesterone Acetate EP Impurity C | Not available | C24H34O4 |
| Medroxyprogesterone Acetate EP Impurity D | 2242-65-1 | C24H34O4 |
| Medroxyprogesterone Acetate EP Impurity E | 32634-95-0 | C24H32O4 |
| Medroxyprogesterone Acetate EP Impurity F | 69688-15-9 | C24H36O4 |
| Medroxyprogesterone Acetate EP Impurity G | 595-33-5 | C24H32O4 |
| Medroxyprogesterone Acetate EP Impurity I | Not available | C22H32O3 |
| Medroxyprogesterone acetate for peak identification | 71-58-9 | C24H34O4 |
| Medroxyprogesterone acetate for system suitability | 71-58-9 | C24H34O4 |
| Medroxyprogesterone Acetate Imp. A (EP): 6 -Hydroxy-6-methyl-3,20- dioxopregn-4-en-17-yl Acetate (6 -Hydroxymedroxyprogesterone Acetate) | 984-47-4 | C24H34O5 |
| Medroxyprogesterone Acetate Imp. B (EP): 17-Hydroxy-6 -methylpregn-4- ene-3,20-dione (Medroxyprogesterone) | 520-85-4 | C22H32O3 |
| Medroxyprogesterone Acetate Imp. E (EP): 6-Methylidene-3,20-dioxopregn-4- en-17-yl Acetate (6-Methylenehydroxyprogesterone Acetate) | 32634-95-0 | C24H32O4 |
| Medroxyprogesterone Acetate Imp. F (EP): 6 -Methyl-3,20-dioxo-5 -pregnan- 17-yl Acetate (4,5 -Dihydromedroxyprogesterone Acetate) | 69688-15-9 | C24H36O4 |
| Medroxyprogesterone Acetate Imp. G (EP): 6-Methyl-3,20-dioxopregna- 4,6-dien-17-yl Acetate (Megestrol Acetate) | 595-33-5 | C24H32O4 |
| Medroxyprogesterone Acetate Imp. H (EP): 3,20-Dioxopregn-4-en-17-yl Acetate (Hydroxyprogesterone Acetate) | 302-23-8 | C23H32O4 |
| Medroxyprogesterone Acetate Impurity 1 | 984-46-3 | C24H34O5 |
| Medroxyprogesterone Acetate Impurity 3 | 113891-99-9 | C24H36O4 |
| Medroxyprogesterone Acetate Impurity 4 | 1072923-65-9 | C24H34O5 |
| Medroxyprogesterone Acetate Impurity 5 | 1072923-64-8 | C24H34O5 |
| Medroxyprogesterone Acetate Impurity 14 | 1097-51-4 | C21H28O3 |
| Medroxyprogesterone Acetate Impurity 15 | 28018-91-9 | C21H29BrO3 |
| Medroxyprogesterone Acetate Impurity 16 | 2128317-86-0 | C31H41NO4 |
| Medroxyprogesterone Acetate Impurity 17 | 16319-93-0 | C25H36O4 |
| Medroxyprogesterone acetate impurity F | 69688-15-9 | C24H36O4 |
| Medroxyprogesterone acetate Related Compound B | 520-85-4 | C22H32O3 |
| Mefenamic Acid 1,2,3-Propanetriol Esters (Mixture of Isomers) | Not available | C36H42N2O8 |
| Mefenamic Acid 1,2-Propylene Glycol Esters (Mixture of Isomers) | Not available | C36H42N2O6 |
| Mefenamic Acid 1,3-Butylene Glycol Esters (Mixture of Isomers) | Not available | C38H46N2O6 |
| Mefenamic Acid 2,3-Butylene Glycol Ester | 95093-55-3 | C19H23NO3 |
| Mefenamic Acid Ethyl Ester | 1226-33-1 | C17H19NO2 |
| Mefenamic Acid Imp. A (EP): 2,3-Dimethylaniline | 87-59-2 | C8H11N |
| Mefenamic Acid Imp. B (EP): N-(2,3-Dimethylphenyl)-2- [(2,3-dimethylphenyl)amino]benzamide | 21122-68-9 | C23H24N2O |
| Mefenamic Acid Imp. C (EP): 2-Chlorobenzoic Acid | 118-91-2 | C7H5ClO2 |
| Mefenamic Acid Imp. D (EP): Benzoic Acid | 65-85-0 | C7H6O2 |
| Mefenamic acid impurity A | 87-59-2 | C8H11N |
| Mefenamic Acid Isopropyl Ester | Not available | C18H21NO2 |
| Mefenamic Acid Isopropyl Ester | 2732673-37-7 | C18H21NO2 |
| Mefenamic Acid Methyl Ester | 1222-42-0 | C16H17NO2 |
| Mefloquine | 53230-10-7 | C17H16F6N2O |
| Mefloquine EP Impurity A | 35853-55-5 | C17H8F6N2O |
| Mefloquine EP Impurity B | 68496-04-8 | C17H10F6N2O |
| Mefloquine Hydrochloride Imp. C (EP) as Hydrochloride: (RS)-[2,8-Bis(trifluoromethyl) quinolin-4-yl][(2RS)-piperidin-2-yl]methanol Hydrochloride (threo-Mefloquine Hydrochloride) | 58560-52-4 | C17H17ClF6N2O |
| Mefloquine Hydrochloride-D9 | 1217653-15-0 | C17H17ClF6N2O |
| Mefloquine Impurity 4 | 35853-50-0 | C12H5F6NO2 |
| Mefloquine Impurity 5 | 58560-52-4 | C17H17ClF6N2O |
| Mefloquine Impurity 6 | 35853-41-9 | C11H5F6NO |
| Mefloquine Related Compound A | 51744-85-5 | C17H16F6N2O |
| Mefloquine Related Compound A (threo-mefloquine) | Not available | C17H16F6N2O |
| Megesterol Acetate Related Compound H | 907193-65-1 | C25H34O4 |
| Megesterol Acetate Related Compound H | 907193-65-1 | C25H34O4 |
| Megestrol acetate EP impurity G | 1259198-59-8 | C25H34O4 |
| Megestrol acetate for peak identification | 595-33-5 | C24H32O4 |
| Megestrol acetate for system suitability | 595-33-5 | C24H32O4 |
| Megestrol Acetate Imp. A (EP): 6 -Methyl-3,20-dioxopregn-4- en-17-yl Acetate (Medroxyprogesterone Acetate) | 71-58-9 | C24H34O4 |
| Megestrol Acetate Imp. K (EP): 3,20-Dioxopregn-4-en-17-yl Acetate | 302-23-8 | C23H32O4 |
| Megestrol Acetate Related Compound C | 74910-22-8 | C24H32O4 |
| Megestrol Acetate Related Compound D | 32634-95-0 | C24H32O4 |
| Megestrol Acetate Related Compound D | 32634-95-0 | C24H32O4 |
| Melamine | 108-78-1 | C3H6N6 |
| Melamine Monoamide | 645-93-2 | C3H4N4O2 |
| Melaminsulfone-d3 Sodium Salt | Not available | C12H14N3NaO4S |
| Melatonin USP related compound A | 608-07-1 | C11H14N2O |
| Meldonium impurity A | 2840-24-6 | C3H10BrN |
| Meldonium impurity B | 34810-18-9 | C3H11BrN2 |
| Meldonium impurity C | 106966-25-0 | C7H17BrN2O2 |
| Meldonium impurity D | 76144-84-8 | C8H19BrN2O2 |
| Meldonium impurity E | 1093122-25-8 | C9H21BrN2O2 |
| Meldonium impurity F | Not available | C5H12N2O2 |
| Melengestrol Acetate Related B | 80097-73-0 | C25H32O4 |
| Melengestrol Acetate Related Compound A (17-hydroxy-16-methylenepregna-4- ene-3,20-dione 17-acetate) | Not available | C24H32O4 |
| Melengestrol Acetate Related Compound A hydrochloride | 6815-51-6 | C24H32O4 |
| Melengestrol Acetate Related Compound B (6,16-dimethylene-17-hydroxypregna- 4-ene-3,20-dione 17-acetate) | Not available | C25H32O4 |
| Meloxicam EP Impurity A | 24683-26-9 | C12H13NO5S |
| Meloxicam EP Impurity B | 7305-71-7 | C4H6N2S |
| Meloxicam EP Impurity C | 1262333-25-4 | C15H15N3O4S2 |
| Meloxicam EP Impurity D | 1331636-17-9 | C16H17N3O4S2 |
| Meloxicam EP Impurity E | 35511-15-0 | C11H11NO5S |
| Meloxicam EP Impurity F | 118854-48-1 | C13H15NO5S |
| Meloxicam Imp. A (EP): Ethyl 4-Hydroxy-2-methyl- 2H-1,2-benzothiazine-3-carboxylate 1,1- Dioxide | 24683-26-9 | C12H13NO5S |
| Meloxicam Imp. B (EP): 5-Methylthiazol-2-amine | 7305-71-7 | C4H6N2S |
| Meloxicam Imp. E (EP): Methyl 4-Hydroxy-2-methyl- 2H-1,2-benzothiazine-3-carboxylate 1,1- Dioxide | 35511-15-0 | C11H11NO5S |
| Meloxicam Imp. F (EP): Isopropyl 4-Hydroxy-2-methyl-2H- 1,2-benzothiazine-3-carboxylate 1,1-Dioxide (1-Methylethyl 4-Hydroxy-2-methyl-2H-1,2- benzothiazine-3-carboxylate 1,1-Dioxide) | 118854-48-1 | C13H15NO5S |
| Meloxicam impurity | Not available | C15H15N3O4S2 |
| Meloxicam Impurity 1 HCl | 929568-25-2 | C4H7ClN2O |
| Meloxicam Impurity 4 | 52188-11-1 | C9H7NO5S |
| Meloxicam Impurity 6 | 13165-80-5 | C7H6O4S |
| Meloxicam Impurity 7 | 1391051-96-9 | C15H15N3O4S2 |
| Meloxicam Impurity 8 | 632-25-7 | C7H6O5S |
| Meloxicam Impurity 9 | 125372-22-7 | C8H9NO4S |
| Meloxicam Impurity 10 | 130262-93-0 | C14H11N3O6S2 |
| Meloxicam Impurity 11 | 130262-92-9 | C14H13N3O5S2 |
| Meloxicam Impurity 17 | 1797124-56-1 | C14H13N3O5S2 |
| Meloxicam Impurity 18 | 881399-30-0 | C16H17N3O4S2 |
| Meloxicam Impurity 19 | 892395-41-4 | C15H15N3O4S2 |
| Meloxicam Impurity 20 | 24683-25-8 | C10H10N2O4S |
| Meloxicam Impurity 22 | 63220-36-0 | C9H7NO2S |
| Meloxicam impurity A | 24683-26-9 | C12H13NO5S |
| Meloxicam impurity B | 7305-71-7 | C4H6N2S |
| Meloxicam impurity C | Not available | C15H15N3O4S2 |
| Meloxicam impurity D | Not available | C16H17N3O4S2 |
| Meloxicam Impurity E | 35511-15-0 | C11H11NO5S |
| Meloxicam impurity standard | 71125-38-7 | C14H13N3O4S2 |
| Meloxicam Related Compound B | 7305-71-7 | C4H6N2S |
| Meloxicam Related Compound C | 118854-48-1 | C13H15NO5S |
| Meloxicam-13C-D3 | 1309936-00-2 | C14H13N3O4S2 |
| Melperone N-Oxide | 2724690-02-0 | C16H22FNO2 |
| Melperone N-Oxide | Not available | C16H22FNO2 |
| Melphalan EP lmpurity A | 72143-20-5 | C13H20N2O4 |
| Melphalan EP lmpurity B | 1259994-01-8 | C13H18N2O3 |
| Melphalan EP lmpurity C | 573704-41-3 | C11H15ClN2O2 |
| Melphalan EP lmpurity D | 61733-01-5 | C13H19ClN2O3 |
| Melphalan EP lmpurity H | 88457-23-2 | C14H20Cl2N2O2 |
| Melphalan EP lmpurity I | 573704-40-2 | C14H21ClN2O3 |
| Melphalan for system suitability | 3223-07-2 | C13H19Cl3N2O2 |
| Melphalan Imp. K (EP): N-Ethylethanamine (Diethylamine) | 109-89-7 | C4H11N |
| Melphalan lmpurity 10 | 1270153-04-2 | C13H18N2O3 |
| Melphalan lmpurity 12 | 2724878-97-9 | C13H17Cl3N2O2 |
| Melphalan lmpurity 14 | 685847-78-3 | C13H18Cl2N2O3 |
| Memantine Glycine | 1340545-88-1 | C14H23NO2 |
| Memantine hydrochloride | 41100-52-1 | C12H22ClN |
| Memantine Related Compound A | 702-79-4 | C12H20 |
| Memantine Related Compound B | 707-37-9 | C12H20O |
| Memantine Related Compound C | 707-36-8 | C12H19Cl |
| Memantine Related Compound D | 941-37-7 | C12H19Br |
| Memantine Related Compound E | 351329-88-9 | C13H21NO |
| Memantine Related Compound E (N- 3,5-Dimethyladamantan-1-yl formamide) | Not available | C13H21NO |
| Memantine Related Compound F | 356572-08-2 | C12H22ClNO |
| Memantine Related Compound G | 33103-93-4 | C11H20ClN |
| Memantine Related Compound H | 15210-60-3 | C13H24ClN |
| Memantine Related Compound I | 80121-67-1 | C12H22ClN |
| Menaquinone 4-d7 (Mixture of cis-trans isomers) | 1233937-25-1 | C31H40O2 |
| Menaquinone 9 | 523-39-7 | C55H78O2 |
| Mepacrine N-Oxide Dihydrochloride | Not available | C23H32Cl3N3O2 |
| Mephenitoin | 50-12-4 | C12H14N2O2 |
| Mephenytoin impurity 1 | 61837-65-8 | C12H14N2O3 |
| Mepivacaine Hydrochloride Imp. A (EP): 2,6-Dimethylaniline | 87-62-7 | C8H11N |
| Mepivacaine Hydrochloride Imp. B (EP) as Hydrochloride: (RS)-N-(2,6- Dimethylphenyl)piperidine-2-carboxamide Hydrochloride | 65797-42-4 | C14H21ClN2O |
| Mepivacaine Hydrochloride Imp. B (EP): (RS)-N-(2,6-Dimethylphenyl)piperidine-2- carboxamide | 15883-20-2 | C14H20N2O |
| Mepivacaine Hydrochloride Imp. C (EP): N-(2,6-Dimethylphenyl)- pyridine-2-carboxamide | 39627-98-0 | C14H14N2O |
| Mepivacaine impurity B | 15883-20-2 | C14H20N2O |
| Mepivacaine N-Oxide | 1346597-75-8 | C15H22N2O2 |
| Mepyramine impurity A | 52818-63-0 | C13H14N2O |
| Mepyramine impurity C | 504-29-0 | C5H6N2 |
| Mepyramine Maleate Imp. A (EP): N-(4-Methoxybenzyl)pyridin- 2-amine | 52818-63-0 | C13H14N2O |
| Mepyramine Maleate Imp. B (EP): 4-Methoxybenzaldehyde (Anisaldehyde) | 123-11-5 | C8H8O2 |
| Mepyramine Maleate Imp. C (EP): Pyridin-2-amine | 504-29-0 | C5H6N2 |
| Mepyramine N-Oxide Dihydrochloride | Not available | C17H23N3O2 |
| Mepyramine N-Oxide Maleate | Not available | C21H27N3O6 |
| Mequitazine N-Oxide | Not available | C20H22N2OS |
| Mequitazine Sulfone N-Oxide | Not available | C20H22N2O3S |
| Mequitazine Sulfone N-Oxide (Mequitazine N,S,S-Trioxide) | Not available | C20H22N2O3S |
| Mequitazine Sulfoxide | 40765-34-2 | C20H22N2OS |
| Mequitazine Sulfoxide N-Oxide | 62705-13-9 | C20H22N2O2S |
| Mequitazine Sulfoxide N-Oxide (Mequitazine N,S-Dioxide) | 62705-13-9 | C20H22N2O2S |
| Mercaptopurine | 50-44-2 | C5H4N4S |
| Mercaptopurine impurity A | 68-94-0 | C5H4N4O |
| Mercaptopurine impurity A CRS | 68-94-0 | C5H4N4O |
| Mercaptopurine impurity B | 73-24-5 | C5H5N5 |
| Mercaptopurine impurity D | 49808-20-0 | C10H6N8S2 |
| Mercaptopurine impurity D CRS | 49808-20-0 | C10H6N8S2 |
| Mercaptopurine impurity standard | 6112-76-1 | C5H6N4OS |
| Mercaptopurine impurity standard | 6112-76-1 | C5H6N4OS |
| Mercaptotriazole | Not available | C2H3N3S |
| Meropenem | 96036-03-2 | C17H25N3O5S |
| Meropenem EP impurity A | 1053703-36-8 | C17H27N3O6S |
| Meropenem EP impurity B | 166901-45-7 | C34H50N6O10S2 |
| Meropenem Impurity 8 | 96035-15-3 | C15H19N3O5S |
| Meropenem Impurity 9 | 96035-23-3 | C15H19N3O5S |
| Meropenem impurity 9 | 90822-24-5 | C17H18N4O7 |
| Meropenem impurity 10 | 96034-64-9 | C15H19N3O5S |
| Meropenem Impurity 12 | 96034-57-0 | C13H14N2O7 |
| Meropenem Impurity 17 | 104873-15-6 | C17H18N2O7 |
| Meropenem Impurity 20 | 936226-36-7 | C30H36N6O10S2 |
| Meropenem impurity 24 | 90776-58-2 | C14H27NO4Si |
| Meropenem impurity 28 | 151072-00-3 | C13H12N2O5S |
| Meropenem impurity 31 | 96036-02-1 | C32H35N5O11S |
| Mertansine | 139504-50-0 | C35H48ClN3O10S |
| Mesalazine EP Impurity C-D4 | 121887-11-4 | C6H7NO |
| Mesalazine EP Impurity D | 99-05-8 | C7H7NO2 |
| Mesalazine EP Impurity E | 65-49-6 | C7H7NO3 |
| Mesalazine EP Impurity F | 570-23-0 | C7H7NO3 |
| Mesalazine EP Impurity F HCl | 17839-48-4 | C7H8ClNO3 |
| Mesalazine EP Impurity G | 490-79-9 | C7H6O4 |
| Mesalazine EP Impurity H Sodium Salt | 54-21-7 | C7H5NaO3 |
| Mesalazine EP Impurity I | 3147-53-3 | C13H10N2O3 |
| Mesalazine EP Impurity J | 112725-89-0 | C7H8N2O3 |
| Mesalazine EP Impurity L | 118-91-2 | C7H5ClO2 |
| Mesalazine EP Impurity M | 2516-96-3 | C7H4ClNO4 |
| Mesalazine EP Impurity N | 96-97-9 | C7H5NO5 |
| Mesalazine EP Impurity O Sodium Salt | 515-74-2 | C6H6NNaO3S |
| Mesalazine EP Impurity P | 887256-40-8 | C13H11NO6S |
| Mesalazine EP Impurity Q | 3970-35-2 | C7H4ClNO4 |
| Mesalazine EP Impurity R | 85-38-1 | C7H5NO5 |
| Mesalazine EP Impurity S | 1797983-23-3 | C14H12N2O5 |
| Mesalazine Ethyl Ester | 62773-65-3 | C9H11NO3 |
| Mesalazine for system suitability | 89-57-6 | C7H7NO3 |
| Mesalazine Imp. A (EP): 4-Aminophenol | 123-30-8 | C6H7NO |
| Mesalazine Imp. B (EP): 3-Aminophenol | 591-27-5 | C6H7NO |
| Mesalazine Imp. C (EP): 2-Aminophenol | 95-55-6 | C6H7NO |
| Mesalazine Imp. D (EP): 3-Aminobenzoic Acid | Not available | C7H7NO2 |
| Mesalazine Imp. F (EP): 3-Amino-2-hydroxybenzoic Acid (3-Aminosalicylic Acid) | 570-23-0 | C7H7NO3 |
| Mesalazine Imp. G (EP): 2,5-Dihydroxybenzoic Acid | 490-79-9 | C7H6O4 |
| Mesalazine Imp. H (EP): 2-Hydroxybenzoic Acid (Salicylic Acid) | 69-72-7 | C7H6O3 |
| Mesalazine Imp. I (EP): 2-Hydroxy-5-(phenyldiazenyl)benzoic Acid (Phenylazosalicylic Acid) | 3147-53-3 | C13H10N2O3 |
| Mesalazine Imp. K (EP) as Hydrochloride: Aniline Hydrochloride | 142-04-1 | C6H8ClN |
| Mesalazine Imp. L (EP): 2-Chlorobenzoic Acid | 118-91-2 | C7H5ClO2 |
| Mesalazine Imp. M (EP): 2-Chloro-5-nitrobenzoic Acid | 2516-96-3 | C7H4ClNO4 |
| Mesalazine Imp. N (EP): 2-Hydroxy-5-nitrobenzoic Acid (5-Nitrosalicylic Acid) | 96-97-9 | C7H5NO5 |
| Mesalazine Imp. O (EP): 4-Aminobenzenesulfonic Acid (Sulfanilic Acid) | 121-57-3 | C6H7NO3S |
| Mesalazine Impurity 01 | 1689-82-3 | C12H10N2O |
| Mesalazine Impurity 02 | 14474-22-7 | C13H10N2O2 |
| Mesalazine Impurity 03 | 2437-11-8 | C12H10N2O |
| Mesalazine Impurity 04 | 40038-46-8 | C13H10N2O3 |
| Mesalazine Impurity 05 | 2362-57-4 | C12H10N2O |
| Mesalazine Impurity 06 | 136819-59-5 | C13H10N2O3 |
| Mesalazine Impurity 22 | 143228-42-6 | C7H5NO3 |
| Mesalazine Impurity 23 | 5794-62-7 | C7H4O4 |
| Mesalazine Impurity 26 | 51-59-2 | C9H9NO4 |
| Mesalazine Impurity 27 | 93968-80-0 | C10H11NO4 |
| Mesalazine Impurity 28 | 93968-81-1 | C11H13NO4 |
| Mesalazine Impurity 29 | 104786-99-4 | C8H7NO4 |
| Mesalazine Impurity 30 | 123135-21-7 | C13H17NO8 |
| Mesalazine Impurity 31 | 859964-08-2 | C8H7NO5 |
| Mesalazine Impurity 32 | 89469-52-3 | C9H7NO3 |
| Mesalazine Impurity 33 | 876903-48-9 | C13H11NO5 |
| Mesalazine impurity A | 123-30-8 | C6H7NO |
| Mesalazine Isopropyl Ester | 64240-87-5 | C10H13NO3 |
| Mesalazine Methyl Ester | 42753-75-3 | C8H9NO3 |
| Mesalazine-13C6 Hydrochloride | 1261398-47-3 | C7H8ClNO3 |
| Mesalazine-D3 Hydrochloride | 1346601-18-0 | C7H8ClNO3 |
| Mesityl Oxide | 141-79-7 | C6H10O |
| Mesna Impurity 1 | 1823982-49-5 | C4H9N3O4S2 |
| Mesna impurity C | 69536-71-6 | C4H8O4S2 |
